Our largest ever investment in Scotland | Cancer Research UK

The search for new and improved cancer treatments is going to receive a major boost, thanks to our largest ever investment in Scotland of up to £123 million.
We’ll provide this funding as part of a seven-year commitment to our Scotland Institute (formerly known as our Beatson Institute). This will bolster Scotland as a major global hub for cancer research on an increasingly competitive world stage, and help with the recruitment of talented researchers from around the globe.
Each year around 34,100 people are diagnosed with cancer in Scotland, so it’s vital we find new ways to tackle the disease.* While around 16,300 Scots sadly lose their lives to the disease each year**, cancer death rates have fallen by 8% over the past decade - largely thanks to research.*** 
*Based on the average annual number of new cases of all cancers (ICD10 C00-C97, excluding C44) diagnosed in Scotland in the years 2017 - 2019  
**Based on the average annual number of deaths from all cancers (ICD10 C00-C97) in Scotland in the years 2017-2019 
***Based on the percentage change of annual average European age-standardised mortality rates in Scotland from 337 deaths per 100,000 people to 309 deaths per 100,000 people for all cancers (ICD10 C00-C97) between 2007-2009 and 2017-2019.
The Cancer Research UK Scotland Institute is based on the University of Glasgow Garscube Campus, Bearsden, Glasgow. 
Subscribe: / cancerresearchuk
Facebook: / cancerresearchuk
Twitter: / cr_uk
Instagram: / cr_uk